Faatz Henrik, Lommatzsch Albrecht
Eye Center, St. Franziskus Hospital Münster, 48145 Münster, Germany.
Achim Wessing Institute for Imaging in Ophthalmology, University of Essen-Duisburg, 45147 Essen, Germany.
J Clin Med. 2024 Aug 25;13(17):5042. doi: 10.3390/jcm13175042.
The aim of this review is to present and discuss the use of optical coherence tomography angiography (OCTA) in age-related macular degeneration (AMD). OCTA is a non-invasive imaging procedure that gives a detailed indirect view of physiological and pathological vessels in the retina and choroid membrane. Compared with dye-based imaging, OCTA provides a segmented presentation of the individual vascular layers and plexuses, thus enabling previously unattainable differentiation and classification of pathological vascular changes within or underneath the retina. In particular, OCTA facilitates early detection of exudative macular neovascularizations (MNV) so that treatment with anti-VEGF medication can be initiated. Moreover, in the context of both screening and therapy monitoring, it is hoped that OCTA can provide more detailed data to enable greater personalization of treatment and follow-up. The image quality of OCTA is, however, susceptible to artifacts, and validation of the results by studies is required. Recent developments have shown constant improvement both in the algorithms for image calculation and avoidance of artifacts and in image quality, so the scope of OCTA will certainly expand with time.
本综述的目的是介绍和讨论光学相干断层扫描血管造影(OCTA)在年龄相关性黄斑变性(AMD)中的应用。OCTA是一种非侵入性成像检查,能对视网膜和脉络膜中的生理和病理血管进行详细的间接观察。与基于染料的成像相比,OCTA可对各个血管层和血管丛进行分层显示,从而能够对视网膜内或其下方的病理性血管变化进行以往无法实现的鉴别和分类。特别是,OCTA有助于渗出性黄斑新生血管(MNV)的早期检测,以便启动抗VEGF药物治疗。此外,在筛查和治疗监测方面,希望OCTA能够提供更详细的数据,以实现治疗和随访的更大个性化。然而,OCTA的图像质量容易受到伪影的影响,需要通过研究对结果进行验证。最近的进展表明,在图像计算和伪影避免算法以及图像质量方面都在不断改进,因此OCTA的应用范围肯定会随着时间的推移而扩大。